BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33565506)

  • 1. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
    J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
    Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
    J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study.
    Hao MZ; Lin HL; Chen Q; Ye YB; Chen QZ; Chen MS
    Chin J Cancer; 2010 Feb; 29(2):172-7. PubMed ID: 20109346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X
    Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC.
    Iezzi R; Posa A; Tanzilli A; Carchesio F; Pompili M; Manfredi R
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
    Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
    Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokine-induced killer cells transfusion following minimally invasive and interventional therapy for early-stage hepatocellular carcinoma:a long-term study].
    Dong A; Li W; Wu F; Huang Z; Xia J; Wu P
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(33):2668-72. PubMed ID: 26711819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R; Shen L; Zhao L; Guan Z; Chen Q; Li W
    Diagn Interv Radiol; 2018 Jul; 24(4):219-224. PubMed ID: 29792289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma.
    Liu C; Liang P; Liu F; Wang Y; Li X; Han Z; Liu C
    Int J Hyperthermia; 2011; 27(7):654-62. PubMed ID: 21966941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of RFA and TACE combined with postoperative cytokine-induced killer cell immunotherapy in primary hepatocellular carcinoma.
    Ji Q; Fu Y; Zhu X; Wang L; Ling C
    J BUON; 2021; 26(1):235-242. PubMed ID: 33721457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.